Consolidated statement of cash flows

Consolidated statement of cash flows

for the year ended September 30, 2024

EUR 000

2023/2024

2022/2023

Profit for the year

628

Adjustments for:

Income tax expense

13

2,238

1,907

Impairment trade receivables and contract assets

1,401

189

Depreciation and amortization

15, 16

38,424

36,927

Net impairment loss

15

88

Finance income

11

-2,099

-899

Finance expenses

12

9,339

9,971

Cash flows before movements in working capital and provisions

49,303

48,811

Change in contract assets

6

-6,515

-4,093

Change in receivables

18

-5,643

-45,303

Change in other assets

408

2,560

Change in contract liabilities

6

468

-3,915

Change in trade and other payables

24

11,325

10,379

Change in provisions

23

-40,106

43,063

Change in employee benefits

22

10,165

-10,129

Cash flows from operating activities

19,405

41,373

Income tax paid

-1,934

-2,344

Net cash from operating activities

17,471

39,029

Acquisition of property, plant and equipment

16

-3,730

-6,019

Investment in software

15

-1,256

-2,578

Net cash used in investing activities

-4,986

-8,597

Additional share premium paid by Coöperatie KPMG U.A.

2,460

2,310

Net proceeds/(repayment) of loans and borrowings from partners

21

30,008

-35,638

Net proceeds/(repayment) of loans and borrowings from former partners

21

1,316

-1,234

Interest paid to Coöperatie KPMG U.A. re partners and former partners

12

-5,454

-5,945

Repayment of share premium to Coöperatie KPMG U.A.

-990

-1,320

Interest and bank charges paid

-4,170

-4,054

Interest received

11

2,099

899

Payment of lease liabilities

-31,187

-29,453

Proceeds of employee bonds

21

1,517

2,040

Repayment of employee bonds

21

-1,661

-1,150

Net cash used in financing activities

-6,062

-73,545

Net change in cash and cash equivalents

6,423

-43,113

Cash and cash equivalents as at October 1

136,154

179,267

Cash and cash equivalents as at September 30

19

142,577

136,154

The accompanying notes are an integral part of these consolidated financial statements.